Page 35 - Read Online
P. 35

Page 34                                             Berardo et al. J Transl Genet Genom 2020;4:22-35  I  https://doi.org/10.20517/jtgg.2020.02

                   ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency. Hum Mutat 2018;39:69-79.
               43.  Stenmark P, Grünler J, Mattsson J, Sindelar PJ, Nordlund P, et al. A new member of the family of di-iron carboxylate proteins. Coq7 (clk-1),
                   a membrane-bound hydroxylase involved in ubiquinone biosynthesis. J Biol Chem 2001;276:33297-300.
               44.  Freyer C, Stranneheim H, Naess K, Mourier A, Felser A, et al. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using
                   2,4-dihydroxybensoic acid. J Med Genet 2015;52:779-83.
               45.  Wang Y, Smith C, Parboosingh JS, Khan A, Innes M, et al. Pathogenicity of two COQ7 mutations and responses to 2,4-dihydroxybenzoate
                   bypass treatment. J Cell Mol Med 2017;21:2329-43.
               46.  Kwong A, Chiu A, Tsang M, Lun K, Richard J, et al. A fatal case of COQ7-associated primary coenzyme Q 10 deficiency. JIMD Rep
                   2019;47:23-9.
               47.  García-Corzo L, Luna-Sánchez M, Doerrier C, García JA, Guarás A, et al. Dysfunctional Coq9 protein causes predominant
                   encephalomyopathy associated with CoQ deficiency. Hum Mol Genet 2013;22:1233-48.
               48.  Lohman DC, Forouhar F, Beebe ET, Stefely MS, Minogue CE, et al. Mitochondrial COQ9 is a lipid-binding protein that associates with
                   COQ7 to enable coenzyme Q biosynthesis. Proc Natl Acad Sci U S A 2014;111:E4697-705.
               49.  Duncan AJ, Bitner-Glindzicz M, Meunier B, Costello H, Hargreaves IP, et al. A nonsense mutation in COQ9 causes autosomal-recessive
                   neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 2009;84:558-66.
               50.  Rahman S, Hargreaves I, Clayton P, Heales S. Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 2001;139:456-8.
               51.  Danhauser K, Herebian D, Haack TB, Rodenburg RJ, Strom TM, et al. Fatal neonatal encephalopathy and lactic acidosis caused by a
                   homozygous loss-of-function variant in COQ9. Eur J Hum Genet 2016;24:450-4.
               52.  Smith AC, Ito Y, Ahmed A, Schwartzentruber JA, Beaulieu CL, et al. A family segregating lethal neonatal coenzyme Q 10 deficiency caused
                   by mutations in COQ9. J Inherit Metab Dis 2018;41:719-29.
               53.  Olgac A, Öztoprak Ü, Kasapkara ÇS, Kılıç M, Yüksel D, et al. A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation. J
                   Pediatr Endocrinol Metab 2020;33:165-70.
               54.  Zhang, X. Exome sequencing greatly expedites the progressive research of mendelian diseases. Front Med 2014;8:42-57.
               55.  Yang Y, Muzny DM, Xia F, Niu Z, Person R, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA
                   2014;312:1870-9.
               56.  Taylor JC, Martin HC, Lise S, Broxholme J, Cazier JB, et al. Factors influencing success of clinical genome sequencing across a broad
                   spectrum of disorders. Nat Genet 2015;47:717-26.
               57.  Chong JX, Buckingham KJ, Jhangiani SN, Boehm C, Sobreira N, et al. The genetic basis of Mendelian phenotypes: discoveries, challenges,
                   and opportunities. Am J Human Genet 2015;97:199-215.
               58.  Yubero D, Allen G, Artuch R, Montero R. The value of coenzyme q10 determination in mitochondrial patients. J Clin Med 2017;6:37.
               59.  Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006;40:445-53.
               60.  Zaki NM. Strategies for oral delivery and mitochondrial targeting of CoQ10. Drug Deliv 2016;23:1868-81.
               61.  Kwong LK, Kamzalov S, Rebrin I, Bayne V AC, Jana CK, et al. Effects of coenzyme Q(10) administration on its tissue concentrations,
                   mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 2002;33:627-38.
               62.  Montini G, Malaventura C, Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med
                   2008;358:2849-50.
               63.  Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion 2007;7:S78-88.
               64.  Auré K, Benoist JF, Ogier de Baulny H, Romero NB, Rigal O, et al. Progression despite replacement of a myopathic form of coenzyme Q10
                   defect. Neurology 2004;63:727-9.
               65.  López LC, Quinzii CM, Area E, Naini A, Rahman S, et al. Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and
                   vitamin C: time- and compound-dependent effects. PLoS One 2010;5:e11897.
               66.  Kleiner G, Barca E, Ziosi M, Emmanuele V, Xu Y, et al. CoQ 10 Supplementation Rescues Nephrotic Syndrome Through Normalization of
                   H 2 S Oxidation Pathway. Biochim Biophys Acta Mol Basis Dis 2018;1864:3708-22.
               67.  Saiki R, Lunceford AL, Shi Y, Marbois B, King R, et al. Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with
                   mutations in prenyl diphosphate synthase subunit 2. Am J Physiol Renal Physiol 2008;295:F1535-44.
               68.  García-Corzo L, Luna-Sánchez M, Doerrier C, Ortiz F, Escames G, et al. Ubiquinol-10 ameliorates mitochondrial encephalopathy
                   associated with CoQ deficiency. Biochim Biophys Acta 2014;1842:893-901.
               69.  Herebian D, López LC, Distelmaier F. Bypassing human CoQ10 deficiency. Mol Genet Metab 2018;123:289-91.
               70.  Herebian D, Seibt A, Smits SHJ, Rodenburg RJ, Mayatepek E, et al. 4-Hydroxybenzoic acid restores CoQ 10 biosynthesis in human COQ2
                   deficiency. Ann Clin Transl Neurol 2017;4:902-8.
               71.  Luna-Sánchez M, Díaz-Casado E, Barca E, Tejada MA, Montilla-García A, et al. The clinical heterogeneity of coenzyme Q10 deficiency
                   results from genotypic differences in the Coq9 gene. EMBO Mol Med 2015;7:670-87.
               72.  Acosta Lopez M, Trevisson E, Canton M, Vazquez-Fonseca L, Morbidoni V, et al. Vanillic acid restores coenzyme Q biosynthesis and ATP
                   production in human cells lacking COQ6. Oxid Med Cell Longev 2019;2019:3904905.
               73.  Ozeir M, Muhlenhoff U, Webert H, Lill R, Fontecave M, et al. Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation
                   reaction and substrate analogs rescue Coq6 deficiency. Chem Biol 2011;18:1134-42.
               74.  Park E, Ahn YH, Kang HG, Yoo KH, Won NH, et al. COQ6 mutations in children with steroid-resistant focal segmental glomerulosclerosis
                   and sensorineural hearing loss. Am J Kidney Dis 2017;70:139-44.
               75.  Doimo M, Trevisson E, Airik R, Bergdoll M, Santos-Ocaña C, et al. Effect of vanillic acid on COQ6 mutants identified in patients with
                   coenzyme Q10 deficiency. Biochim Biophys Acta 2014;1842:1-6.
   30   31   32   33   34   35   36   37   38   39   40